4.3 Article

Phytate inhibits bovine pericardium calcification in vitro

Journal

CARDIOVASCULAR PATHOLOGY
Volume 17, Issue 3, Pages 139-145

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.carpath.2007.08.005

Keywords

crystallization inhibitor; cardiovascular calcification; bovine pericardium; pyrophosphate; etidronate; phytate

Ask authors/readers for more resources

Objective: The present study examined the inhibitory effects of pyrophosphate, etidronate, and phytate on bovine pericardium calcification in vitro. Methods: Bovine pericardium was glutaraldehyde fixed and then placed in a flow chamber in the presence of a synthetic physiological fluid alone (control) or the fluid plus various concentrations of pyrophosphate, etidronate, or phytate. Following a 96-h incubation, fragments were removed and assayed for calcification by measuring calcium and phosphorus levels. Results: The data indicated that both pyrophosphate and etidronate at 1mg/l (5.75 and 4.95 mu M, respectively) inhibited bovine pericardium calcification, whereas neither agent had an effect at 0.5 mg/l (2.87 and 2.47 mu M, respectively). Phytate was the most potent inhibitor of calcification, and the effects of this agent were apparent at levels as low as 0.25 mg/l (0.39 mu M). Conclusions: While pyrophosphate, etidronate, and phytate were all able to the most effective. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis

Smeeta Sinha, Lisa J. Gould, Sagar U. Nigwekar, Thomas E. Serena, Vincent Brandenburg, Sharon M. Moe, George Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Stephan Miller, Claire Padgett, Kevin J. Carroll, Joan Perello, Alex Gold, Glenn M. Chertow

Summary: The CALCIPHYX trial is a Phase 3 clinical trial aimed at evaluating the efficacy and safety of SNF472 in patients with ulcerated calciphylaxis lesions who are receiving hemodialysis. The trial will assess endpoints such as wound healing, pain relief, and wound-related quality of life.

CLINICAL KIDNEY JOURNAL (2022)

Article Nutrition & Dietetics

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

Jose Ignacio Ramirez Manent, Barbara Altisench Jane, Pilar Sanchis Cortes, Carla Busquets-Cortes, Sebastiana Arroyo Bote, Luis Masmiquel Comas, Angel Arturo Lopez Gonzalez

Summary: This study assessed the impact of unhealthy lifestyles during lockdown on health parameters. The results showed that the unhealthy habits during lockdown resulted in negative effects on body weight, BMI, percentage of body fat, total cholesterol levels, LDL levels, and glucose levels, leading to a worsening of cardiovascular risk factors.

NUTRIENTS (2022)

Article Biochemistry & Molecular Biology

Phytate Dephosphorylation Products Also Act as Potent Inhibitors of Calcium Oxalate Crystallization

Felix Grases, Antonia Costa-Bauza, Paula Calvo, Francesca Julia, Jaume Dietrich, Rosa Maria Gomila, Gabriel Martorell, Pilar Sanchis

Summary: Phytate consumption has no adverse effects on a balanced diet, and has been found to prevent pathological calcifications. Hydrolysis of phytate produces inositol phosphates (InsPs) that also have biological activity. InsP6 and its hydrolysis products effectively inhibit calcium oxalate crystallization. It is important to develop simple analytical methods to quantify the level of individual InsPs.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

Phytate Intake, Health and Disease: Let Thy Food Be Thy Medicine and Medicine Be Thy Food

Antelm Pujol, Pilar Sanchis, Felix Grases, Luis Masmiquel

Summary: Phytate, found in wholegrains, legumes, and oilseeds, is a recognized nutraceutical that has been shown to treat or prevent certain diseases. It has antioxidation and anti-inflammatory effects, inhibiting calcium salt crystallization, reducing vascular calcifications, and playing a role in bone mass loss treatment. Phytate also improves lipid and carbohydrate metabolism, reduces protein glycation, and shows promise in neurodegenerative disease treatment.

ANTIOXIDANTS (2023)

Article Biochemistry & Molecular Biology

Efficacy of Different Modalities and Frequencies of Physical Exercise on Glucose Control in People with Prediabetes (GLYCEX Randomised Trial)

Aina M. Galmes-Panades, Miquel Bennasar-Veny, Paula Oliver, Natalia Garcia-Coll, Alice Chaplin, Sergio Fresneda, Laura Gallardo-Alfaro, Carmen Garcia-Ruano, Jadwiga Konieczna, Alfonso Leiva, Lluis Masmiquel, Catalina Pico, Ignacio Ricci-Cabello, Dora Romaguera, Rosmeri Rivera, Pilar Sanchis, Josep Vidal-Conti, Aina M. Yanez

Summary: This is a two-phase randomized controlled clinical trial aimed at assessing the effectiveness of different types and frequencies of physical exercise on glycaemic control in adults with prediabetes. The study will collect various biomedical data and questionnaires to evaluate the impact of interventions on health.

METABOLITES (2022)

Article Nutrition & Dietetics

Estimated Phytate Intake Is Associated with Bone Mineral Density in Mediterranean Postmenopausal Women

Pilar Sanchis, Rafael Maria Prieto, Jadwiga Konieczna, Felix Grases, Itziar Abete, Jordi Salas-Salvado, Vicente Martin, Miguel Ruiz-Canela, Nancy Babio, Jesus Francisco Garcia-Gavilan, Albert Goday, Antonia Costa-Bauza, Jose Alfredo Martinez, Dora Romaguera

Summary: The main objective of this study was to examine the relationship between dietary phytate intake and bone mineral density (BMD) in a Mediterranean population of postmenopausal women. The results showed that phytate intake was positively associated with BMD in Mediterranean postmenopausal women, indicating a potential protective effect on bone. However, further large-scale, long-term, and randomized prospective clinical studies are needed to assess the potential benefits of phytate consumption on BMD in postmenopausal women.

NUTRIENTS (2023)

Article Nutrition & Dietetics

Diet in Different Calcium Oxalate Kidney Stones

Iris Coello, Pilar Sanchis, Enrique C. Pieras, Felix Grases

Summary: Dietary choices can influence the formation of different types of kidney stones. Processed food and meat derivatives are associated with papillary COM stones, while consuming enough calcium may offer protection against non-papillary COM stones. Dairy product consumption is linked to COD stones. A diet high in animal items increases the risk of papillary COM stones, while consuming calcium or dairy products may be preventive or a risk factor for non-papillary COM and COD stones respectively.

NUTRIENTS (2023)

Article Endocrinology & Metabolism

Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial

Pilar Sanchis, Paula Calvo, Antelm Pujol, Rosmeri Rivera, Francisco Berga, Regina Fortuny, Antonia Costa-Bauza, Felix Grases, Luis Masmiquel

Summary: This study found that supplementation of phytate can increase plasma adiponectin concentration and decrease HbA1c levels in patients with type 2 diabetes mellitus (T2DM), which could have beneficial effects in preventing and minimizing diabetic-related complications.

NUTRITION & DIABETES (2023)

Article Urology & Nephrology

Effect of theobromine on dissolution of uric acid kidney stones

Francesca Julia, Antonia Costa-Bauza, Francisco Berga, Felix Grases

Summary: N-acetylcysteine showed a modest effect on the dissolution of uric acid stones, while theobromine significantly increased their dissolution. The combination of both substances had a similar effect to theobromine alone. Adding theobromine to a therapy that uses citrate and/or bicarbonate may be a new strategy for the oral chemolysis of uric acid stones.

WORLD JOURNAL OF UROLOGY (2022)

Article Cardiac & Cardiovascular Systems

GDF5 deficiency prevents cardiac rupture following acute myocardial infarction in mice

Eric A. Shikatani, Tao Wang, Luke S. Dingwell, Colin White-Dzuro, Abdul Momen, Mansoor Husain

Summary: This study found that GDF5 deficiency can reduce the incidence of cardiac rupture after myocardial infarction and improve survival rates in mice. Additionally, GDF5 deficiency leads to increased myocardial fibrosis and decreased afterload. However, it also results in the occurrence of chronic adverse remodeling.

CARDIOVASCULAR PATHOLOGY (2024)

Review Cardiac & Cardiovascular Systems

Digital pathology in cardiac transplant diagnostics: from biopsies to algorithms

Martin Kveton, Lukas Hudec, Ivan Vykopal, Matej Halinkovic, Miroslav Laco, Andrea Felsoova, Wanda Benesova, Ondrej Fabian

Summary: This comprehensive review explores the transformative role of digital pathology and computational pathology, especially through machine learning, in the field of heart transplantation. These methodologies have the potential to enhance diagnostic outcomes and reduce observer variability by extracting valuable information from large datasets beyond human perceptual capabilities. However, challenges such as limited sample sizes, diverse data sources, and the absence of standardized protocols hinder the widespread adoption of these techniques.

CARDIOVASCULAR PATHOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Characteristics of Lambl excrescences of aortic and pulmonary valves in healthy hearts

Abhinav Goyal, Andrew J. Layman, Melanie C. Bois, Joseph J. Maleszewski

Summary: This study examined the prevalence and characteristics of Lambl excrescences (LEs) in 403 healthy human hearts and found that the prevalence of LEs in healthy hearts is far lower than previously reported.

CARDIOVASCULAR PATHOLOGY (2024)